DCMS News & Announcements

Click on the titles below for detailed information. In addition to the highlighted items below, stay connected with the weekly DMJ Newsletter. To subscribe or for questions, email communications@dallas-cms.org.

Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after comple
The analysis included a period from Jan. 15 to Oct. 1 with a particular focus on the four weeks from Sept. 4 to Oct. 1, which allowed the agency to measure the effect of COVID-19 vaccination as the more contagious Delta variant surged across Texas.
The ETS establishes binding requirements to protect unvaccinated employees of large employers (100 or more employees from the risk of contracting COVID-19 in the workplace.
CDC recommends everyone ages 5 and older get a COVID-19 vaccine to help protect against COVID-19.
The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.
Physicians and faith leaders from North Texas teamed up for frank and honest conversations that dispel misinformation about the COVID-19 vaccines.
TMA raised “grave concerns” in the comment letter about the current budget-neutrality requirement with Medicare physician payments.
DCMS past president, John Carlo, MD, testified yesterday in Austin in front of the Texas Senate Affairs committee to oppose SB 51, where he asked lawmakers to exempt healthcare entities from the law’s reach.
Have questions about coadministering the COVID-19 and Flu vaccines? The CDC has put together a helpful FAQ.
The application is now open for both Provider Relief Fund (PRF) Phase 4 and American Rescue Plan (ARP) Rural payments. The application will close on October 26, 2021 at 11:59 p.m. ET.
DCMS is looking to gather survey data regarding employee management, benefits, an administration in order to help DCMS determine if additional resources and services would be of value to our members.
Efficacy of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions.
The Dallas County Public Health Committee is providing an FAQ to assist physicians and the community with understanding the current status of Pfizer booster vaccines.
Become involved in your profession by applying for a leadership position with DCMS, or nominating a colleague that DCMS should consider for volunteer service.
As students and staff have begun to return to the classroom during this most recent surge, members have asked for additional tools to assist them in working with local schools and districts in Dallas County regarding masking policies.
Learn more regarding the changes to the physician referral system for sending patients to the Ft. Worth and McKinney COVID-19 monoclonal antibody infusion centers.